Gilead Sciences (GILD)
$63.10 0.33 (0.52%)
12:36 EST GILD Stock Quote Delayed 15 Minutes
Previous Close $63.43
Market Cap 82.05B
PE Ratio 23.99
Volume (Avg. Vol.) 4.42M
Day's Range 62.74 - 63.47
52-Week Range 60.89 - 70.50
Dividend & Yield 2.23 (3.53%)
GILD Stock Predictions, Articles, and Gilead Sciences News
- From InvestorPlace
- From the Web
PayPal, Slack, and chip stocks like AMD and Nvidia, Micron and Nio were all big movers in the Nasdaq today. Get the scoop, now.
If you’re looking for the next big thing in investing, these three down but not out biotech stocks are the way to go.
Allergan looks to still be in a downtrend, while Etsy stock is fighting with resistance at $70 and Boeing hurdles the 50-day moving average.
The stock charts of GILD, DISH and MCK are put under the trading microscope as the next great trading prospects.
Gilead Sciences, Pfizer, Tesla, Netflx and Facebook are our top stock trades for Tuesday. Here's a look at the charts.
This morning, I am recommending a bullish trade on Gilead Sciences, Inc. (NASDAQ:GILD), the biopharmaceutical company.
Nvidia, American Airlines, Teva, AMD and Gilead Sciences are our top stock trades to watch for Wednesday. See the charts here.
If you're looking for good stocks to buy, here are seven ideas from one of America's best public pension plans.
Gilead has been dead money for some time and with good reason. Still, it seems that much of the bad news is baked into GILD stock.
Tesla, Gilead, Twitter, The Trade Desk and Realty Income are our top stock trades to watching going into Tuesday morning's trading session.
Think all blue-chip stocks are safe buys at any time? Think again. These companies may be about to stumble, if they haven't already.
Gilead stock has been stagnating, but there are other choices for investors. How about considering Celgene over GILD stock?
Corning, Netflix and Phillips 66 all have brewing breakouts, making them some of our must-see stock charts for Wednesday.
Gilead Sciences stock was on its way down Tuesday after releasing data from a recent Phase 3 clinical trial concerning its drug selonsertib.
Alphabet, Gilead Sciences and Estee Lauder all reported earnings. Starbucks and Boeing are breaking out. Here's our top stock trades.
Gilead Sciences earnings came in below what analysts projected, while revenue beat expectations, but GILD stock declined after hours Monday.
Biotech stocks are off to a hot start in 2019, and these five stocks, in particular, could be the next winners.
From The Motley Fool
From Market News Video
Navellier RatingsPowered by Portfolio Grader